Kalorama Information studies on the pharmaceutical vaccines industry cover the global market opportunity in full, with data on major competitors, market direction, and the pediatric and adult segments. Kalorama reports examine the global vaccines market by region, including the US, South America, EU, Japan, India, and China, as well as by type, including hepatitis, pneumococcal, cervical cancer, and influenza, among others. Market share of major vaccine companies is reported as well.
Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information’s report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET […]
The vaccine market is poised for a rather substantial increase in the next five years due to the number of vaccines in development and the push for a COVID-19 vaccine. As the COVID-19 outbreak advanced worldwide, companies stepped up to the challenge, scrambling to provide a potential vaccine. In addition to discussion of COVID-19 vaccine […]
Vaccines 2018-2024: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus, HIB, Others) Vaccines 2018: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments provides a complete global revenue summary, including the total global market for preventive vaccines by type for 2015 to 2024 […]
Vaccines 2016: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments (Influenza, Cervical Cancer, Combinations, Hepatitis, Pneumococcal, MMR, Varicella, Poliovirus , HIB, Others) Vaccines: The World Market analyzes the revenues for vaccines used in humans to prevent various types of disease. The report provides a comprehensive revenue summary, including revenue growth of vaccines vs. […]
This report, the World Market for Cancer Therapeutics presents a detailed picture of the market for cancer drugs, with a focus on novel therapies. The market analysis in this report includes analysis of products avaiable for each cancer type (Breast Cancer, Lung Cancer, Prostate Cancer, Stomach Cancer, Lymphoma, Colon Cancer and Other types) including Monoclonal […]
Biopharmaceutical and Vaccine Production Markets Biopharmaceutical and Vaccine Production Markets analyzes the entire manufacturing market for biologic drugs, including both outsourcing and costs by major maufacturers spending internally on biopharmaceutical and vaccine production. As part of its coverage, the following information is provided Market Size and Projections Vaccine Manufacturing Estimates Biologic Drug Methods Trend Analysis […]
Vaccines 2014: World Market Analysis, Key Players, Trends, Pediatric and Adult Segments The global market for human vaccines experienced strong growth through 2013 with the introduction of new vaccines. These new products and other trends are well-covered in Vaccines: The World Market. The Kalorama information report examines the global market for vaccines, covering specifically commercialized […]
This Kalorama Information report – The Next Wave in Cancer Treatment–Kinase Inhibitors – is focused on a growing area of cancer treatment, kinase inhibitors. Several cancers are being treated with these newer therapies, which provide a focus of cancer profiled in this report, including: Breast Colorectal Head/Neck Kidney Leukemia Liver Lung Melanoma Ovarian Pancreatic Prostate […]
Vaccines are an important part of the business model of top pharmaceutical companies. The success of several recent vaccine product introductions has been of great interest to pharma R&D efforts. The high growth rates and successful launch of several products recently have kept interest in the global vaccine market high. The global market for vaccines […]
This report examines the market for vaccines used in humans to previous various types of disease. It covers only commercialized vaccines and developmental vaccines for diseases that are already vaccine-preventable; it does not cover emerging vaccines for diseases that are not currently vaccine-preventable, such as Alzheimer’s disease, diabetes, Ebola infection, Epstein-Barr virus (EBV) infection, ETEC […]
Kalorama Information, part of Science and Medicine Group, has been a leading publisher of market research in medical markets, including the biotechnology, diagnostics, medical device, and pharmaceutical industries for more than 30 years. Our comprehensive, timely, quality research and innovative approach to analysis and presentation of market intelligence have made Kalorama Information a premier source of market information for top industry decision makers.